CDK4/6 inhibitors, including ribociclib, may cause organising pneumonia that closely mimics lung cancer on CT and FDG-PET. Histological confirmation is essential in discordant cases.
Franco, G., Promi, S., Galbardi, I., Paciocco, G., Allegranza, P., Cangiotti, C., et al. (2026). A hypermetabolic pulmonary lesion in a patient with breast cancer. BREATHE, 22(2) [10.1183/20734735.0042-2026].
A hypermetabolic pulmonary lesion in a patient with breast cancer
Promi, Samuele;Galbardi, Isabella;Zanini, Umberto;Pagni, Fabio;Faverio, Paola;Guerra, Luca;Cortinovis, Diego Luigi;Cazzaniga, Marina Elena;Luppi, Fabrizio
2026
Abstract
CDK4/6 inhibitors, including ribociclib, may cause organising pneumonia that closely mimics lung cancer on CT and FDG-PET. Histological confirmation is essential in discordant cases.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Breathe-2026-Franco-260042.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
938.35 kB
Formato
Adobe PDF
|
938.35 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
